Learn Mode

TEM - Tempus AI Inc

99

$46.84

-$0.19 (-0.404%)

4/2/26, 6:17 PM

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

TEM

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$8.20B

Industry

Life Sciences Tools & Services

EPS (TTM)

-$1.37

P/E (TTM)

0.00

Div & Yield

FCF Payout Ratio

P/S (TTM)

6.45

P/B

16.70

Diluted Shares

178.15M

Ex-Dividend

Next Earnings

05-01

Forward P/E

0.00

Payout Ratio

P/FCF (TTM)

0.00

FCF Yield

Earnings Yield

-2.99%

52 Week Range

Score Card

Explore Scores Tab

Tempus AI Inc has grown revenue at 83.41% over the past year, which is strong growth. However, it has seen its diluted average shares outstanding increase by 6.74% over the past year, which suggests the company is diluting shareholders.

Valuation Model

Key Score

Management

1.00

Very Bad

Growth

1.00

Very Bad

Profitability

1.00

Very Bad

Fin. Health

1.00

Very Bad

Dividends

Analyst

1.00

Very Bad

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

2 new filings were in the last 7 days

Filter Form Types

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-27 21:46:17

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-27 13:32:45

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-26 16:27:22

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-03-06 14:47:19

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:30:27

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:30:25

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-02 16:40:16

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-02 16:38:26

Form 3

Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-02-25 19:12:07

Form S-8

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Filed on 2026-02-24 16:58:11

Form 10-K

Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-24 16:06:41

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-24 16:01:24

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-03-25

High:

$105.00

124.2%

Avg:

$81.05

73.0%

Low:

$58.58

25.1%

(% change is relative to the current stock price: $46.84)

Analyst Recommendations

Go to Analyst Tab

3.87

Good

26%

Strong Buy (6)

35%

Buy (8)

39%

Hold (9)

Sell (0)

Strong Sell (0)

About

Website
https://investors.tempus.com/
Address
600 West Chicago Avenue, Suite 510, Chicago ILLINOIS, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1717115

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

IPO Date

2025-05-30

Industry

Life Sciences Tools & Services

Total Employees

3,800

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

TEM - Tempus AI Inc

99

$46.84

-$0.19 (-0.404%)

Stock Unlock

Stock Profile

Score Card

Insider Transactions

Market News

Form 4

Filed on 2026-03-27 21:46:17

Form SCHEDULE 13G/A

Filed on 2026-03-27 13:32:45

Form 144

Filed on 2026-03-26 16:27:22

Form SCHEDULE 13G

Filed on 2026-03-06 14:47:19

Form 4

Filed on 2026-03-04 16:30:27

Form 4

Filed on 2026-03-04 16:30:25

Form 144

Filed on 2026-03-02 16:40:16

Form 144

Filed on 2026-03-02 16:38:26

Form 3

Filed on 2026-02-25 19:12:07

Form S-8

Filed on 2026-02-24 16:58:11

Form 10-K

Filed on 2026-02-24 16:06:41

Form 8-K

Filed on 2026-02-24 16:01:24

Financials

Price Targets

124.2%

73.0%

25.1%

Analyst Recommendations

About

Similar Stocks